About investor relations

Henry Schein at a Glance

About investor relations

$12.6B IN SALES IN 2022


Our Q4 Results Reflect

  • We closed out 2022 with a very good fourth quarter in which we continued to execute effectively on our 2022 to 2024 Strategic Plan goals, achieving strong growth in earnings for the fourth quarter and the full year.
  • Excluding sales of PPE products and COVID-19 test kits and adjusting for the 53rd sales week, we achieved very good internal sales growth of 5.0% in local currencies.

At Henry Schein, Inc., our customers rely on us for an exceptional experience

Delivering differentiated solutions that make their practices more successful and improve patient outcomes. We are trusted advisors and consultants to our customers – enabling them to deliver the best quality patient care and enhance their practice management efficiency and profitability.

With more than 3,400 field sales consultants (including equipment sales specialists), approximately 2,100 telesales representatives, and more than 170 equipment sales and service centers worldwide, Henry Schein helps customers succeed by offering the products and services needed for delivering high-quality health care.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.